Clinical Trial Update: First-line Therapy With Nivolumab Plus Ipilimumab in Combination With Chemotherapy for Metatastatic NSCLC (NICReWo Trial)

View source ↗

Summary

Clinical trial update describing a first-line strategy for metastatic non-small cell lung cancer using nivolumab plus ipilimumab in combination with chemotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Non Small Cell Lung Cancer Metastatic | Status: RECRUITING